As NMDAR dysfunction is implicated in diseases including autism, epilepsy and schizophrenia, our work suggests that future studies could look for abnormal NMDAR glycosylation, especially at GluN1 N440 and GluN2B N688 residues, in the studies of various neurological disorders. The gene discussed is GRIN1; the disease is autism.